BillionToOne, Inc. (BLLN)
BillionToOne, Inc. (BLLN) is a healthcare company (diagnostics & research) based in the United States. The share price is $96.79, up 0.50% on the day, which values the company at $4.62B. Price as of 17 Nov 2026, 17:31 UTC, from Yahoo Finance.
Key facts
- Share price
- $96.79+0.50% today
- Market value
- $4.62B
- P/E ratio
- 105.2×last 12 months
- Forward P/E
- 61.6×
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
BillionToOne, Inc. in more detail
BLLN trades at 105.2× its last twelve months' earnings, 61.6× next year's expected earnings, 10.6× sales.
In its favour: Altman Z in the safe zone; Strong Piotroski score.
3 of the superinvestors tracked here hold BLLN, including Ron Baron (0.1% of the portfolio), Baillie Gifford team (0.1% of the portfolio), Polen Capital team (0.1% of the portfolio).
Superinvestors holding BLLN
3 of the investors tracked here report a position in their latest 13F filing.
- Ron Baron Baron Capital (BAMCO)0.13% of portfolio · $79.2M · added · Q3 2026
- Baillie Gifford team Baillie Gifford & Co0.11% of portfolio · $115.1M · added · Q3 2026
- Polen Capital team Polen Capital Management0.05% of portfolio · $4.6M · added · Q3 2026
Health Care companies of similar size
- VeradermicsMANE
- GrifolsGRFS
- Cogent BiosciencesCOGT
- GRAILGRAL
- LifeStance Health GroupLFST
- Hims & Hers HealthHIMS
- PTC TherapeuticsPTCT
- HaemoneticsHAE
- ErascaERAS
- Concentra Group Holdings ParentCON
- Merit Medical SystemsMMSI
- Edgewise TherapeuticsEWTX
Side by side:BLLN vs LFST (BillionToOne, Inc. vs LifeStance Health Group)BLLN vs HIMS (BillionToOne, Inc. vs Hims & Hers Health)BLLN vs PTCT (BillionToOne, Inc. vs PTC Therapeutics)BLLN vs HAE (BillionToOne, Inc. vs Haemonetics)BLLN vs ERAS (BillionToOne, Inc. vs Erasca)
All health care companies by market valueLargest companies in the United StatesAll stocks A–Z
BillionToOne, Inc. (BLLN): questions and answers
What is BLLN's P/E ratio?
BillionToOne, Inc. trades at 105.2× its last twelve months' earnings and 61.6× next year's expected earnings.
What is BillionToOne, Inc.'s market cap?
BillionToOne, Inc. is valued at $4.62B at a share price of $96.79.
Does BLLN pay a dividend?
BillionToOne, Inc. does not currently pay a regular dividend.
Which famous investors own BLLN?
In their latest quarterly filings, Ron Baron (0.1% of the portfolio), Baillie Gifford team (0.1% of the portfolio), Polen Capital team (0.1% of the portfolio) hold BLLN. These filings are published up to 45 days after each quarter ends, so positions may have changed since.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “BillionToOne, Inc. (BLLN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/BLLN
Underlying data: Yahoo Finance; company filings with the SEC.